|
WirelessDevNet.com Press Release
Epocrates Reigns as Physicians' Top Mobile App According to New Manhattan Research Study
Epocrates, Inc. (Nasdaq:EPOC) continues its market leadership in the digital medical category, according to the recently released Manhattan Research Taking the Pulse(R) U.S. 2012 annual study of physicians' technology adoption and behavior.
Relevant findings from the Taking the Pulse U.S. study include:
-
Epocrates is the number one medical app among physicians in terms of reach, both on smartphones and tablets.
-
Among physicians using the Epocrates app on a smartphone, more than half use it daily.
-
Drug references are the top digital resources accessed by physicians during patient consultations on a smartphone.
"Epocrates is the first place many physicians turn for concise, trusted information, as demonstrated by these findings," said Andy Hurd, president and chief executive officer for Epocrates. "We are committed to continuing to deliver the clinical content and tools they need in the exact time, place and format they want to access it."
Taking the Pulse U.S. 2012 is a physician research study and advisory service fielded annually by Manhattan Research focused on understanding technology adoption and current and future use among U.S. practicing physicians. The survey was conducted among a randomized sample of 3,015 U.S. practicing physicians using an online survey fielded in March and April 2012.
About Epocrates, Inc.
Epocrates, Inc. (Nasdaq:EPOC) is a leading physician platform for clinical content, practice tools and health industry engagement at the point of care. The Epocrates network consists of more than one million healthcare professionals, including 50 percent of U.S. physicians, who routinely use its solutions and services. Epocrates' portfolio includes top-ranked medical apps, such as the industry's #1 medical app among U.S. physicians, and valuable manufacturer resources. Through these intuitive and reliable resources, Epocrates supports clinical decisions, helps improve physician workflow and impacts patient outcomes. For more information, please visit www.epocrates.com/company.
Epocrates is a trademark of Epocrates, Inc., registered in the U.S. and other countries.
|
